![](/img/cover-not-exists.png)
Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)
Jennifer M. Specht, Stephen L. Tam, Brenda F. Kurland, Julie R. Gralow, Robert B. Livingston, Hannah M. Linden, Georgiana K. Ellis, Erin K. Schubert, Lisa K. Dunnwald, David A. MankoffVolume:
105
Language:
english
Pages:
8
DOI:
10.1007/s10549-006-9435-1
Date:
September, 2007
File:
PDF, 241 KB
english, 2007